<p>(A) Test sensitivities of MMR and of symptom screening are varied from 0% to 100%. Colored regions indicate combinations of test sensitivities for which sputum PCR screening (maroon), symptom screening (yellow), and MMR (blue) are the least costly of the three screening strategies evaluated. (B) Test sensitivities of MMR and of symptom screening are varied from 0% to 100%. Colored regions indicate the ICER of sputum PCR screening compared with the next best strategy, divided into the following: cost-saving (yellow), non-dominated and ICER</p
<p>(A) Sensitivity analysis of studies evaluated intratumoral neutrophils expression on OS. (B) Sens...
Test sensitivity pertains to the ability of a test to identify subjects with the target disorder. In...
Test sensitivity pertains to the ability of a test to identify subjects with the target disorder. In...
<p>The costs of selective PCR-based screening are depicted on the horizontal ...
<p>Sensitivity analysis: variation in cost/LYG through screening by varied testing and drug costs, p...
<p>Left) Two-way sensitivity analysis of the effects of changes in IGRA sensitivity and specificity ...
Sensitivity analysis results evaluating cost-effectiveness of Histoplasma antigen screening with tre...
<p>Parameters are ranked by the magnitude of their impact on the average ...
One-way sensitivity analysis showing effect of varying sensitivity of IgMFA and clinical diagnosis, ...
Sensitivity analysis results evaluating cost-effectiveness of Histoplasma antigen prevalence of 5%.<...
<p>For the incremental cost-effectiveness ratio (ICER) to be more favorable for serology than for TB...
Each small dot corresponds to a sensitivity/prevalence pair observed for one combination of the vari...
<p>Comparison of Sensitivity for RIDT and IFA Tests by Severity and Age using PCR as the Gold Standa...
Sensitivity analysis results evaluating cost-effectiveness of Histoplasma antigen prevalence of 15%....
<p>(A) Scanning thresholds. Three different thresholds are depicted for Marker 1 (left) and Marker 2...
<p>(A) Sensitivity analysis of studies evaluated intratumoral neutrophils expression on OS. (B) Sens...
Test sensitivity pertains to the ability of a test to identify subjects with the target disorder. In...
Test sensitivity pertains to the ability of a test to identify subjects with the target disorder. In...
<p>The costs of selective PCR-based screening are depicted on the horizontal ...
<p>Sensitivity analysis: variation in cost/LYG through screening by varied testing and drug costs, p...
<p>Left) Two-way sensitivity analysis of the effects of changes in IGRA sensitivity and specificity ...
Sensitivity analysis results evaluating cost-effectiveness of Histoplasma antigen screening with tre...
<p>Parameters are ranked by the magnitude of their impact on the average ...
One-way sensitivity analysis showing effect of varying sensitivity of IgMFA and clinical diagnosis, ...
Sensitivity analysis results evaluating cost-effectiveness of Histoplasma antigen prevalence of 5%.<...
<p>For the incremental cost-effectiveness ratio (ICER) to be more favorable for serology than for TB...
Each small dot corresponds to a sensitivity/prevalence pair observed for one combination of the vari...
<p>Comparison of Sensitivity for RIDT and IFA Tests by Severity and Age using PCR as the Gold Standa...
Sensitivity analysis results evaluating cost-effectiveness of Histoplasma antigen prevalence of 15%....
<p>(A) Scanning thresholds. Three different thresholds are depicted for Marker 1 (left) and Marker 2...
<p>(A) Sensitivity analysis of studies evaluated intratumoral neutrophils expression on OS. (B) Sens...
Test sensitivity pertains to the ability of a test to identify subjects with the target disorder. In...
Test sensitivity pertains to the ability of a test to identify subjects with the target disorder. In...